Protein kinase Cα expression confers retinoic acid sensitivity on MDA-MB-231 human breast cancer cells

Experimental Cell Research

Volumn 269, Issue 1, 2001, Pages 97-108

  Cho, Yunhi ^a,b   Talmage, David A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Kyung Hee University   (South Korea)

Author keywords

Breast cancer; c fos; MAPK; Protein kinase C; RAR; Retinoic acid; Retinoid

Indexed keywords

PROTEIN KINASE C; RETINOIC ACID; ANTINEOPLASTIC AGENT; CALCIUM; EPIDERMAL GROWTH FACTOR; ISOENZYME; ISOPROPYL THIOGALACTOSIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLASMA PROTEIN; PRKCA PROTEIN, HUMAN; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE C ALPHA; RETINOIC ACID RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; DRUG INTERACTION; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REPORTER GENE;

ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; BREAST NEOPLASMS; CALCIUM; CELL DIVISION; DRUG INTERACTIONS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; ISOENZYMES; ISOPROPYL THIOGALACTOSIDE; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0035839721     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5298     Document Type: Article

References (69)

1. Treatment of benign breast disease with vitamin A
2. Breast cancer chemoprevention
3. Retinoids, retinoid-responsive genes, cell differentiation, and cancer
4. Transcriptional control of c-jun by retinoic acid
5. The pharmacological manipulation of members of the transforming growth factor beta family in the chemoprevention of breast cancer
6. Retinoic acid is a negative regulator of AP-1-responsive genes
7. Retinoic acid inhibits transformation by preventing phosphatidylinositol 3-kinase dependent activation of the c-fos promoter
8. Retinoic acid receptor alpha suppresses polyomavirus transformation and c-fos expression in rat fibroblasts
9. Retinoic acid suppresses polyoma virus transformation by inhibiting transcription of the c-fos proto-oncogene
10. Retinoic acid receptor alpha 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells
11. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function
12. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids
13. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status
14. Retinoic acid induced growth arrest of human breast carcinoma cells requires protein kinase C alpha expression and activity
15. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells
16. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium
17. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
18. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway
19. Overexpression of the Grb2 gene in human breast cancer cell lines
20. Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations
21. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate
22. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase
23. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
24. Phosphorylation and activation of p70s6k by PDK1
25. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
26. Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B
27. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1
28. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1
29. Intracellular signalling: PDK1 - A kinase at the hub of things
30. Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252
31. Inhibition of mitogen-induced c-fos expression in melanoma cells by retinoic acid involves the serum response element
32. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
33. Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: Correlation with altered regulation of proto-oncogene expression by phorbol esters
34. The relationship between susceptibility to retinoic acid treatment and protein kinase C alpha expression in murine melanoma cell lines
35. Regulation of protein kinase C gene expression by retinoic acid in B16 mouse melanoma cells
36. Distinct functions of protein kinase Calpha and protein kinase Cbeta during retinoic acid-induced differentiation of F9 cells
37. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells
38. Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway
39. Retinoic acid receptor alpha mediates growth inhibition by retinoids in human colon carcinoma HT29 cells
40. Defective expression of cellular retinol binding protein type I and retinoic acid receptors alpha2, beta2, and gamma2 in human breast cancer cells
41. A safe packaging line for gene transfer: Separating viral genes on two different plasmids
42. Efficiency of plasmid delivery and expression after lipid-mediated gene transfer to human cells in vitro
43. Protein measurement with filin phenol reagent
44. Ubiquitination of protein kinase C-alpha and degradation by the proteasome
45. Activation of protein kinase C triggers its ubiquitination and degradation
46. Protein kinase C(alpha) actively downregulates through caveolae-dependent traffic to an endosomal compartment
47. Increased expression of protein kinase C alpha plays a key role in retinoic acid-induced melanoma differentiation
48. Cloning and characterization of the murine PKC alpha promoter: Identification of a retinoic acid response element
49. Increased PKA and PKC activities accompany neuronal differentiation of NT2/D1 cells
50. Identification of heregulin, a specific activator of p185erbB2
51. p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells
52. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements
53. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers
54. Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition and apoptosis by retinoic acid in cancer cells
55. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization
56. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid
57. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex
58. Serine 157, a retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARalpha heterodimerization and transcriptional activity
59. A protein kinase C-dependent activity modulates retinoic acid-induced transcription
60. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma
61. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma
62. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways
63. Retinoic acid metabolism and inhibition of cell proliferation: An unexpected liaison
64. The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells
65. Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion
66. Retinoid-binding proteins are phosphorylated in vitro by soluble Ca+2- and phosphatidylserine-dependent protein kinase from mouse brain
67. The in vitro characterization of the inhibition of mouse brain protein kinase-C by retinoids and their receptors
68. Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment